2021-01-05,Sutro Biopharma to Present at the 39th Annual J.P. Morgan Virtual Healthcare Conference
2020-12-11,"Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares"
2020-12-08,Sutro Biopharma Announces Pricing of $126.0 Million Public Offering
2020-12-07,Sutro Biopharma Announces Proposed Public Offering of 5 Million Shares of Common Stock
2020-12-07,Sutro Biopharma Presents Data from Ongoing Phase 1 Dose-Escalation Study for STRO-001 for the Treatment of B-cell Non-Hodgkin Lymphoma at the 62nd American Society of Hematology Annual Meeting
2020-12-04,Why Sutro Biopharma Blasted 33% Higher on Friday
2020-12-04,"Why BioCryst, Moderna And More Are Moving Today"
2020-12-04,"The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs"
2020-12-03,Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
2020-12-03,"Why Sutro, Lumos And More Health Care Stocks Are Moving Today"
2020-12-01,"Sutro Biopharma Announces Appointment of Jon M. Wigginton, M.D., to Board of Directors"
2020-11-24,Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer
2020-11-18,Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
2020-11-09,"Sutro Biopharma, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year"
2020-11-05,Sutro Biopharma Reports Third Quarter 2020 Financial Results and Provides Business Highlights and Developments
2020-11-03,"If You Had Bought Sutro Biopharma (NASDAQ:STRO) Stock A Year Ago, You Could Pocket A 27% Gain Today"
2020-10-12,"Hedge Funds Are Dipping Their Toes Into Sutro Biopharma, Inc. (STRO)"
2020-09-21,Sutro Biopharma Named Best New Drug Developer at the 7th Annual World ADC
2020-09-10,"The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Sarepta Flags Potential Delay In Gene Therapy Trial"
2020-09-09,Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting
2020-09-04,"Sutro Biopharma, Inc. (NASDAQ:STRO) Insiders Increased Their Holdings"
2020-09-03,"Macy's, Carnival: 5 Big Stock Gainers for Thursday"
2020-09-03,"The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax"
2020-09-03,Sutro Biopharma to Present at Two Upcoming Investor Conferences
2020-09-02,Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting
2020-09-02,Well Fargo Says These 2 Stocks Could Rally Over 70% From Current Levels
2020-08-25,"Sutro Biopharma Earns Clinical Supply Milestone Payment from Merck KGaA, Darmstadt, Germany for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors"
2020-08-11,Sutro Biopharma Announces Two Executive Promotions to Vice President of Quality and Vice President of Manufacturing
2020-08-10,Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-08-06,"Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Sutro Biopharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights and Developments
2020-08-05,"Will Sutro Biopharma, Inc. (STRO) Report Negative Q2 Earnings? What You Should Know"
2020-06-30,"Were Hedge Funds Right About Souring On Sutro Biopharma, Inc. (STRO)?"
2020-06-22,Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
2020-06-11,"Scott+Scott Attorneys at Law LLP Announces Investigation into Sutro Biopharma, Inc. (STRO)"
2020-06-09,"Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020"
2020-06-08,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO"
2020-06-08,"Got $1,000? Buy These 4 Cancer Stocks"
2020-06-03,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO"
2020-05-27,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO"
2020-05-25,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sutro Biopharma, Inc. - STRO"
2020-05-21,Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
2020-05-21,"Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD"
2020-05-14,"Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares"
2020-05-13,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates ClaimsÂ On Behalf of Investors of Sutro Biopharma, Inc. - STRO"
2020-05-12,"STRO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Sutro Biopharma, Inc. and Encourages Investors to Contact the Firm"
2020-05-11,Sutro Biopharma Announces Pricing of $85.3 Million Public Offering
2020-05-11,Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments
2020-04-27,Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
2020-04-20,"Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate"
2020-04-13,"Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020"
2020-04-13,Will Sutro Biopharma Continue to Surge Higher?
2020-03-26,$110M injection powers up Peninsula vaccine maker  but not for COVID-19
2020-03-26,SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
2020-03-16,"Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates"
2020-03-16,Sutro Biopharma Reports Full Year 2019 Financial Results and Recent Business Highlights and Developments
2020-03-12,Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck
2020-03-04,Sutro Biopharma to Present Innovative Cancer Therapy Approach Using Precise Tumor Targeted Immunostimulants at World ADC London
2020-02-06,Does Sutro Biopharma (NASDAQ:STRO) Have A Healthy Balance Sheet?
2020-02-05,Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
2020-01-09,Sutro Biopharma to Present at 38th Annual J.P. Morgan Healthcare Conference
2020-01-08,Sutro Biopharma Appoints James Panek to Board of Directors
2019-12-19,"Do Hedge Funds Love Sutro Biopharma, Inc. (STRO)?"
2019-11-19,Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference
2019-11-08,"Sutro Biopharma, Inc. (STRO): Hedge Funds Are Snapping Up"
2019-11-08,Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
2019-10-30,"Introducing Sutro Biopharma (NASDAQ:STRO), The Stock That Dropped 15% In The Last Year"
2019-10-29,"The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study"
2019-10-29,Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer
2019-10-27,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings"
2019-10-16,Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
2019-10-08,Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
2019-09-04,Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
2019-09-03,"Targeting flesh-eating, drug-resistant bacteria, Peninsula company grabs small grant for antibiotic"
2019-08-14,Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
2019-08-08,Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
2019-07-31,Is Sutro Biopharma (NASDAQ:STRO) Using Debt In A Risky Way?
2019-07-04,"Heres What Hedge Funds Think About Sutro Biopharma, Inc. (STRO)"
2019-06-24,Sutro Biopharma Appoints Biopharma Veteran Connie Matsui as Board Chair
2019-06-18,Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
2019-06-15,Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data on a Potential First-in-Class Antibody-Drug Conjugate STRO-001 for the Treatment of B-cell Malignancies at the European Hematology Association Congress
2019-05-16,Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
2019-05-15,Sutro Biopharma Reports First Quarter 2019 Financial Results and Recent Business Highlights and Developments
2019-04-08,How free-flowing cash is accelerating small companies' cancer drug trials
2019-04-04,Sutro Biopharma to Present at the 18th Annual Needham Healthcare Conference
2019-04-01,Sutro Biopharma Reports Full Year 2018 Financial Results and Recent Business Highlights and Developments
2019-03-15,Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers
2019-03-05,Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
2019-01-29,Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry
2019-01-03,Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference
2018-12-20,"DAFNA Capital Management Return, AUM and Holdings"
2018-12-19,Sutro Achieves $10 Million Milestone Payment from Celgene
2018-12-05,This year's Bay Area IPO batch remains up 44% despite market turbulence
2018-11-26,Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference
2018-11-14,Sutro Biopharma Reports Third Quarter 2018 Financial Results
2018-11-13,"Sutro Announces IND Submission and Conclusion of 30-Day Review Period for STRO-002, an Antibody-Drug Conjugate (ADC) Targeting Anti-Folate Receptor- for Treatment of Ovarian and Endometrial Cancer"
2018-11-08,Sutro Appoints Industry Veteran Shalini Sharp to Board of Directors
2018-10-12,Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma
2018-10-01,24 Bay Area companies have gone public so far this year. Here's how they've done.
2018-09-27,[$$] Sutro Biopharma's IPO Raises $85 Million
